Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways
Creators
- 1. Hunan University of Chinese Medicine, Changsha, 410208, PR (China)
- 2. Department of Geriatrics, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410007, PR (China)
Description
Highlights: • ISL reversed Ang II-induced inhibition of cell survival, cell cycle arrest and cell apoptosis in HK-2 cells. • Nrf2-mediated oxidative stress was involved in the regulation of Ang II-induced apoptosis by ISL. • ISL inhibited Ang II-induced NF-κB signaling activation and inflammatory cytokines release. • ISL inhibited Ang II-induced excessive deposition of extracellular matrix. Hypertensive renal injury plays important role in the pathogenesis of end-stage nephropathy and the need for dialysis. Isoliquiritigenin (ISL) is a natural compound with antioxidant and anti-inflammatory activities. In this study, the protective effects of ISL on Angiotensin II (Ang II)- induced apoptosis, inflammation and extracellular matrix production in HK-2 cells were observed and its mechanisms were elucidated.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2018.09.013Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2018.09.013;
- PII
- S0006291X18319235;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 506
- Journal Issue
- 1
- Journal Page Range
- p. 161-168
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53017089
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ANGIOTENSIN; ANTIOXIDANTS; CELL CYCLE; DIALYSIS; INFLAMMATION; KIDNEYS; LYMPHOKINES
- Descriptors DEC
- BODY; CARDIOVASCULAR AGENTS; DRUGS; GLOBULINS; GROWTH FACTORS; MITOGENS; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; PROTEINS; SEPARATION PROCESSES; SYMPTOMS; VASOCONSTRICTORS
Optional Information
- Copyright
- Copyright (c) 2018 Published by Elsevier Inc.